Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs aimed at increasing the horizons of cytokine-based immunotherapy, specifically for cancers where therapy solutions remain limited. Use the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline We https://financefeeds.com/xs-com-appoints-stelios-pallis-as-chief-technology-officer/